Tech Company Financing Transactions
Viropro Funding Round
Spring Hill Bioventures participated in a $500 thousand funding round for Viropro. The financing closed on 8/27/2014.
Transaction Overview
Company Name
Announced On
8/27/2014
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will be used for the preparation of audited financial statements, the implementation of the company's strategic plans and for general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2151 O'Toole Ave. 50
San Jose, CA 95131
USA
San Jose, CA 95131
USA
Phone
Website
Email Address
Overview
Viropro is an integrated developer and manufacturer of biopharmaceutical products that address unmet medical need in an efficient and cost-effective way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Bruce Cohen
Browse more venture capital transactions:
Prev: 8/27/2014: FormaFina venture capital transaction
Next: 8/27/2014: AirStrip venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs